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STUDY PROTOCOL Open Access
Maintained physical activity and physiotherapy in
the management of distal upper limb pain – a
protocol for a randomised controlled trial
(the arm pain trial)
Gareth T Jones1,9*, Kathrin Mertens1, Gary J Macfarlane1, Keith T Palmer2, David Coggon2, Karen Walker-Bone2,
Kim Burton3, Peter J Heine4, Candy McCabe5,6, Paul McNamee7 and Alex McConnachie8
Abstract
Background: Distal upper limb pain (pain affecting the elbow, forearm, wrist, or hand) can be non-specific, or can
arise from specific musculoskeletal disorders. It is clinically important and costly, the best approach to clinical
management is unclear. Physiotherapy is the standard treatment and, while awaiting treatment, advice is often
given to rest and avoid strenuous activities, but there is no evidence base to support these strategies. This paper
describes the protocol of a randomised controlled trial to determine, among patients awaiting physiotherapy for
distal arm pain, (a) whether advice to remain active and maintain usual activities results in a long-term reduction in
arm pain and disability, compared with advice to rest; and (b) whether immediate physiotherapy results in a
long-term reduction in arm pain and disability, compared with physiotherapy delivered after a seven week waiting
list period.
Methods/Design: Between January 2012 and January 2014, new referrals to 14 out-patient physiotherapy
departments were screened for potential eligibility. Eligible and consenting patients were randomly allocated to
one of the following three groups in equal numbers: 1) advice to remain active, 2) advice to rest, 3) immediate
physiotherapy. Patients were and followed up at 6, 13, and 26 weeks post-randomisation by self-complete postal
questionnaire and, at six weeks, patients who had not received physiotherapy were offered it at this time. The
primary outcome is the proportion of patients free of disability at 26 weeks, as determined by the modified DASH
(Disabilities of the Arm, Shoulder and Hand) questionnaire.
We hypothesise (a) that advice to maintain usual activities while awaiting physiotherapy will be superior than
advice to rest the arm; and (b) that fast-track physiotherapy will be superior to normal (waiting list) physiotherapy.
These hypotheses will be examined using an intention-to-treat analysis.
Discussion: Results from this trial will contribute to the evidence base underpinning the clinical management of
patients with distal upper limb pain, and in particular, will provide guidance on whether they should be advised to
rest the arm or remain active within the limits imposed by their symptoms.
Trial registration: Registered on www.controlled-trials.com (reference number: ISRCTN79085082).
Keywords: Randomised controlled trial, Arm pain, Physiotherapy, Advice, Rest, Active, Pain management
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Background
Upper limb pain is common and responsible for consid-
erable disability, demand for health care and lost prod-
uctivity. Among working-aged respondents to a recent
population survey in England, 15% had consulted a GP
within the past year with upper limb pain [1]; 5% had
seen a specialist; 14% reported symptoms persisting
more than six months; and 10% reported disabling pain
[2]. Further, data from the UK Labour Force Survey indi-
cate that work-attributed cases of upper limb disorder
cause an estimated annual loss of 4.7 million working
days [3]. Upper limb pain is more likely to become per-
sistent if accompanied by poor mental health, adverse
psychosocial factors, including a somatising tendency
(tendency to be distressed by common physical symp-
toms), and adverse beliefs concerning health and activity
[4,5]. Indeed, it is plausible that response to treatment
may vary importantly between subgroups defined by
such characteristics.
Distal upper limb pain is defined as pain in the elbow,
forearm, wrist or hand, may be non-specific in origin, or
may arise from a number of specific disorders (e.g. med-
ial and lateral epicondylitis, and tenosynovitis). In a
study of patients presenting to primary care and physio-
therapy services with upper limb pain, 42% of patients
had pain in the distal arm and at twelve months 48%
were still in pain, and 19% reported unremitting pain
(never pain-free for as long as seven consecutive days)
[5]. Although distal upper limb pain is clinically import-
ant, and costly, the best approach to managing symp-
toms is unclear.
Evidence for the effectiveness of advice in the treatment
of upper limb pain
Patients with upper limb pain are commonly referred to
physiotherapy and, while awaiting treatment, are often
advised to rest the arm and avoid purported harmful ac-
tivities as a precautionary measure. Indeed, online health
advice offered by the UK National Health Service (NHS)
states that ‘it is likely that your GP will probably advise
you to temporarily stop doing the task or activity that is
causing your symptoms’ [6]. Similarly, many employers
and occupational physicians are wary of allowing em-
ployees with distal upper limb pain to continue with
forceful or repetitive work activities for fear of possible
litigation. However, such advice lacks an evidence base.
A search of MEDLINE and BIDS Embase in 2009 (at the
time the funding application for the current trial was
prepared) confirmed that no randomised controlled trial
has hitherto investigated the benefits of resting the pain-
ful arm as compared with remaining active within the
limits of pain. This omission is both important and sur-
prising. An analogy can be drawn with non-specific
low back pain, which shares many aetiological and
prognostic factors and which for many years was man-
aged by bed rest. However, trials – and, latterly, large-
scale community health campaigns – have demonstrated
that back pain prognosis is improved if patients are ad-
vised to remain active [7,8].
Written information providing evidence-based advice
to patients with back pain (The Back Book) has been
shown to be effective in promoting positive beliefs and
contributing to improved clinical outcomes [9,10]. The
way in which the advice is imparted is based firmly on
a biopsychosocial approach: traditional beliefs about
the relationship between activity and pain are chal-
lenged, the benefits of remaining active are contrasted
with the disadvantages of undue rest, and individuals
are empowered to take responsibility for their recovery.
This differs conceptually from a biomedical approach
in which the patient is a passive recipient who is told
what has gone wrong (injury), how it is diagnosed, and
what healthcare can do to fix it. The activity-promotion
approach has been extended to the management of
neck injury (The Whiplash Book), where a booklet fo-
cusing on reducing anxiety about the injury, and stres-
sing the benefits of remaining active, has been well
received by patients and caused a positive shift in be-
liefs [11]. More recently available is The Arm Book
which also provides evidence based advice on how to
deal with upper limb pain or injury. However, its effect-
iveness is currently unproven [12].
It seems plausible that patients with distal upper limb
pain might benefit from a similar approach to back pain.
Many such cases (like cases of back pain and whiplash
injury) arise in the absence of well-defined local path-
ology, and the natural history and predictors of arm pain
share much in common with these other musculoskel-
etal disorders – fear-avoidance, health anxiety, pessimis-
tic attitudes, psychological distress and adverse
psychosocial factors [4,5,13]. We hypothesise a number
of possible mechanisms through which we may hasten
improvement in function, by challenging disadvanta-
geous beliefs about ‘injury', reducing fear and distress,
and encouraging self-management and the maintenance
of an active approach to recovery. Whether patients with
distal upper limb pain benefit from keeping active, as
back pain sufferers do, is logically the next research
question to address and well-conducted trials are needed
to resolve these issues.
Hypothesis/aims
The primary aim of this study is to investigate whether,
among patients awaiting physiotherapy for distal upper
limb pain (pain in the elbow, forearm, wrist or hand),
advice to remain active and maintain usual activities re-
sults in a long-term reduction in upper limb pain and
disability, compared with advice to rest.
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Potential participants will be identified from patients
with distal upper limb pain referred to physiotherapy.
However, whether physiotherapy itself is efficacious in the
management of distal upper limb pain is not well estab-
lished. Therefore, in the context of the proposed trial, a
pragmatic opportunity exists to determine the value of
early physiotherapy in comparison with treatment that is
delayed until the usual waiting list time. Therefore, a sec-
ondary aim is to determine, among the same patient
population, whether immediate (‘fast-track’) physiotherapy
results in a long-term reduction in upper limb pain and
disability, compared with physiotherapy delivered at the
usual waiting list time – typically, after a period of ap-
proximately seven weeks.
Methods/design
Study design overview
This paper presents the protocol for a multi-centre, ran-
domised, controlled trial. Potentially eligible patients with
distal upper limb pain are identified from waiting lists in
out-patient physiotherapy departments. Recruited patients
undergo telephone screening in the first instance, followed
by a pre-trial assessment by a research nurse, to confirm
eligibility and collect baseline information. Eligible pa-
tients are randomised to one of three groups:
 Group 1 – advice to remain active while awaiting
physiotherapy treatment;
 Group 2 – advice to rest the arm while awaiting
physiotherapy treatment; or
 Group 3 – immediate physiotherapy.
All participants are followed up by postal questionnaire
6, 13 and 26 weeks post-randomisation to determine arm
pain and function. In addition, at six weeks, participants
from Groups 1 and 2 who indicate that they still require
physiotherapy are offered immediate treatment. Thus, this
treatment will be delivered at around seven weeks equat-
ing, approximately, to that on a ‘usual care’ waiting list.
Ethical issues
Ethical approval has been obtained from the South
Central – Hampshire A Research Ethics Committee (11/
SC/0107). All participants are required to provide written
informed consent at initial assessment. Patients are re-
quired to consent to complete the study questionnaire,
undergo the brief examination and, if eligible, to be rando-
mised into one of the treatment groups. Participants are
not being made aware that there are two different types of
advice to prevent compromise of the advice being given.
Identification of potential participants
From January 2012 to January 2014, male and female pa-
tients aged 18 years or older were identified from out-
patient physiotherapy services in fourteen UK trial sites
(see Table 1). Eligibility was established by screening re-
ferral letters for physiotherapy and confirmed by ques-
tioning and physical examination carried out by trained
research nurses during an initial assessment visit. Pa-
tients were potentially eligible if they were referred (or
self-referred) to out-patient physiotherapy for treatment
of distal upper limb pain/disability. However, patients
were excluded if they met one, or more, of the following
criteria: (a) aged <18 yrs at the time of screening; (b) the
patient had received previous physiotherapy for distal
upper limb pain within the past twelve months; (c) the
disorder was of a type for which physiotherapy of
the distal upper limb was not the primary treatment
(e.g. pain referred from the neck/shoulder); (d) the pain
was due to a fracture, systemic inflammatory disease, or
cancer; (e) the patient has complex regional pain syn-
drome; (f ) symptoms were due to a specific condition
for which advice to remain active is contraindicated (e.g.
florid tenosynovitis); (g) the appointment was classed as
an emergency; and/or (h) the patient was embroiled in a
legal dispute regarding their arm pain.
Initial assessment visit
Patients who attended the initial assessment were asked to
self-complete a questionnaire which asked about demo-
graphic characteristics (age, sex, social class); employment
circumstances (including occupational activities); symptom
history (e.g. unilateral or bilateral symptoms, duration,
disability) and all prior treatments to date. In addition,
data were collected on general health, physical and
mental well-being, fatigue, other symptoms (headache/
abdominal pain/chronic widespread pain), somatic
Table 1 Trial recruitment sites
Centre First patient randomised Last patient randomised
Aberdeen 03-Feb-12 04-Feb-14
Southampton 20-Feb-12 29-Apr-13
Brighton 16-Mar-12 07-Feb-14
Sussex 17-Aug-12 27-Dec-13
Stockport 13-Sep-12 23-Jan-14
Newcastle 27-Nov-12 14-Jan-14
Southend 03-Dec-12 19-Nov-13
King’s college 01-Feb-13 28-Jan-14
Wigan 11-Feb-13 10-Feb-14
Huddersfield 14-Feb-13 23-Jan-14
Leicester 14-Mar-13 28-Nov-13
Birmingham 28-Mar-13 06-Jan-14
Bath 08-May-13 18-Feb-14
St Helens 16-May-13 08-Oct-13
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distress, health beliefs (especially fear avoidance) and
smoking status.
Patients also underwent a standardised upper limb
examination: the Southampton Examination Schedule for
Upper Limb Disorders which includes inspection and pal-
pation of the upper limbs, and clinical provocation tests
(including Finkelstein’s test, Phalen’s test and Tinel’s test).
The Schedule is based on a national Delphi consensus,
has been validated in hospital out-patient and community
settings, and has been applied in previous large-scale epi-
demiological studies [14,15].
Both questionnaire and examination assessed factors
were considered as important prognostic markers, poten-
tial modifiers of treatment response, baseline measure of
outcomes, or were important for randomisation and
minimisation.
Randomisation process and allocation concealment
Randomisation was conducted by the Robertson Centre
for Biostatistics, a registered clinical trials unit at the
University of Glasgow.
Patients were allocated to one of the three treatment
groups using a mixed randomisation and minimisation
algorithm to maintain treatment balance with respect to
treatment centre, laterality (dominant, non-dominant,
bilateral), a broad categorisation of diagnosis (elbow dis-
order, or wrist/hand disorder), and baseline arm func-
tion, as assessed using a modified DASH score (the
primary outcome measure, with scores grouped as 0–5,
6–8, or 9–11). For each new patient, the minimisation
variables were entered into a web-based data collection
system, created by the trials unit; the system then allo-
cated the patient to one of the three groups. One third
of patients were allocated completely at random, whilst
two-thirds were allocated according to the minimisation
algorithm. Randomisation to the three groups, or entry
to the minimisation procedure, was determined accord-
ing to a pre-specified allocation schedule generated
using the method of randomised permuted blocks of
nine participants. This schedule was known only to a re-
stricted group of staff at the trials unit. Within the mini-
misation algorithm, in the event of a tie between
treatment groups (i.e. when allocation to more than one
group would provide an equally low level of imbalance),
treatment was allocated at random between the tied
treatment groups.
Blinding
Because of the nature of the interventions, it was not
possible to blind study participants. However, to prevent
‘contamination’ it is important that participants were un-
aware of the differing advice given to others. Therefore,
patients were informed that if they participated, they
would be randomised to immediate physiotherapy or
advice, without giving explicit details about the nature of
the advice (or even the fact that there were two advice
groups).
Treatment groups
 Group 1 – advice to remain active;
Participants randomised to receive advice to remain
active were given a seven-page leaflet focusing on posi-
tively shifting beliefs about activity and arm pain, along
with practical advice on staying active. The messages
were reinforced verbally by a research nurse using a brief
standardised script. The experimental leaflet was devel-
oped from the findings of a recent Health and Safety Ex-
ecutive Research Report of a comprehensive review of
arm pain [16]: this research confirmed that biopsychoso-
cial principles apply to the management of work-related
upper limb disorders and a number of evidence-based
messages were proposed. Key among these were that
upper limb pain is common; early return to work is
helpful; lasting damage is rare; recovery and return to
full activities can be expected; some cases may need
treatment but many settle with self-management; and
that maintaining activity is probably helpful.
These messages are very similar to those that apply to
back and upper limb pain and are amenable to presenta-
tion written form - similar to The Back Book, The Whip-
lash Book, and The Arm Book [9,10,12]. Cognitive
behavioural principles underlie the patient-centred infor-
mation and advice, which focuses on the benefits of
remaining active. The text was prepared by Burton and
Kendall, who led the Health and Safety Executive project
and have experience of producing this sort of patient edu-
cational material, with input from other members of the
Arm Trial research team. The leaflet also underwent fur-
ther review by several colleagues, and by a focus group of
end users, to ensure accuracy, general acceptability and
clarity.
 Group 2 – advice to rest the arm; or
Participants randomised to receive advice to rest the
arm received a leaflet similar in length, design and ap-
pearance to the booklet for Group 1. This leaflet was
based on material available via NHS Direct: it covers a
range of diagnoses, can be taken to reflect current clin-
ical practice, and contrasts with the approach adopted
for the experimental leaflet (Group 1). The style is sol-
idly biomedical and the advice is about rest and avoid-
ance (as well as treatment), rather than maintaining
activity.
 Group 3 – immediate physiotherapy.
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Participants randomised to receive immediate physiother-
apy were fast-tracked to treatment which they received at
the earliest opportunity. Additional physiotherapy staff were
provided in all participating trial centres so initial physio-
therapy assessment (independent of the trial screening
examination) and first treatment would occur in a matter
of days, rather than weeks. Whilst this trial is intended to
be pragmatic in so far as it is reflective of usual physiother-
apy practice, we undertook additional work to ensure the
treatment programmes were compliant with both the Med-
ical Research Council’s and the CONSORT organisation’s
guidance on developing and reporting complex interven-
tions. In the early phases of the study we documented and
developed the intervention to ensure it represents best
usual care. This involved a review of appropriate treatment
guidelines and the literature to ascertain current best prac-
tice. It also included discussions with physiotherapists in-
volved in the trial in order to establish current practice and,
if any differences were encountered, to reconcile the find-
ings of the literature with actual clinical practice. A broad
set of guidelines was developed in accordance with best
practice which gave therapists the flexibility to treat patients
on an individual basis without being overly prescriptive.
Further, it is important that the interventions be docu-
mented so they can be reported and replicated, and the
physiotherapists who deliver the intervention be in-
volved in this process (to facilitate compliance with the
treatment protocol). Treatments were recorded using a
standardised pro forma and record, for example, treat-
ment modality, number and timing of appointments
attended, and time to discharge.
Follow-up and trial outcomes
Follow-up is still ongoing. Participants are followed up at
6, 13, and 26 weeks post-randomisation by self-complete
postal questionnaires, and non-responders receive a re-
minder questionnaire after two weeks. After a further two
weeks, non-responders are followed up by telephone, and
are asked brief questions on the primary outcome only,
using a standardised pro forma. In addition, at six weeks
patients randomised to receive advice (Groups 1 or 2) re-
ceive a letter offering them a physiotherapy appointment
which, if accepted, is received at the earliest opportunity.
This approach, requiring an active opt-in to treatment, is
consistent with current practice for patients not involved
in the trial. Also, the delay between randomisation and the
offer of appointment is equivalent to what would be usual
care physiotherapy in most UK centres. Participants elect-
ing to receive physiotherapy are offered immediate treat-
ment and receive that therapy, as per usual protocol (and
as per Group 3), at the discretion of the treating physio-
therapist. Although the precise treatment modalities given
may differ between fast-track and delayed physiotherapy
groups, this reflects usual care, where treatment choice
may be dependent on time elapsed since initial referral
and activities undertaken in the interim.
The DASH (Disabilities of the Arm, Shoulder and
Hand) questionnaire is an instrument designed to meas-
ure physical function and symptoms in patients with sin-
gle or multiple musculoskeletal disorders of the upper
limb. It has been shown to have good test-retest reliabil-
ity and validity. Further, it has high internal consistency,
correlates well with other measures of arm function, and
discriminates between persons who are/are not able to
undertake activities of daily living, or work without re-
striction [17]. However, the DASH instrument has a
number of important limitations in the context of the
current trial. Specifically, (a) there is a lack of good qual-
ity reference data for the DASH from the United King-
dom; (b) the DASH instrument focuses on the whole of
the upper limb and contains no items that are specific to
the distal arm; (c) none of its elements relate explicitly
to activity limited by pain; (d) the timeframe of inquiry
(past seven days) is likely to limit study power for cer-
tain outcomes (e.g. difficulty changing a light-bulb) and
is less relevant clinically in a trial designed to assess sus-
tained recovery; and (e) some items are relevant only to
subsets of the study population (e.g. preparing meals,
making beds), rather than providing a question set based
on activities that everyone is likely to perform.
Accordingly, we developed a modified instrument to
determine arm function. Based in part and in format on
the original DASH questionnaire, and called here the
'modified DASH', this instrument asks participants to
rate difficulty in performing eleven pre-specified activ-
ities over the previous seven days because of pain in
their distal upper limb (Figure 1). This modified DASH,
which has improved face validity over the DASH for our
purposes, has previously been used in a large population
survey examining the outcome and prognostic determi-
nants for upper limb pain presenting in primary care
and to physiotherapy services [5]. In this pilot phase, the
instrument was shown to be sensitive to change, and
to track clinical recovery over the time interval of
interest. It enables a well-powered, clinically relevant
dichotomous outcome (full recovery versus not) to be
studied.
Thus, for the current trial, the primary outcome is the
proportion of patients free of disability at 26 weeks post-
randomisation, as determined by the modified DASH. As
a secondary outcome for participants randomised to
Group 1/Group 2, we aim to determine the proportion
who still seek physiotherapy at six weeks. In addition, we
collect information on the type of treatments given,
and time to discharge. Other secondary outcomes, in
all participants, include: upper limb pain and func-
tion, coping, fear of movement, ability to function at
work, aspects of general health and quality of life.
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In addition, health care costs will be collected from
participants using structured questionnaires. These will
record distal upper limb related hospital admissions,
out-patient attendances, and visits to/from relevant
health professionals. Published UK sources of data on
unit cost will be applied to value use of resources. For
EQ-5D and SF-12 outcomes, published UK tariffs will be
used to convert these data to quality of life weights.
Statistical issues
Proposed sample size/power calculation
The study is powered to determine a difference in the
proportion of patients fully recovered at 26 weeks post-
randomisation, as assessed using the modified DASH.
The principal analysis will consist of a comparison be-
tween participants in Group 1 and Group 2 (advice to
maintain usual activities, versus advice to rest the arm).
We have previously shown that, among persons with
distal arm pain undergoing usual care, 51% were free of
disability at six months, with little further improvement
(up to 60%) at 12 months [5]. The trial is powered on
the assumption that 70% of participants in Group 1 will
be free of disability at six months. We require 148 sub-
jects in each group in order to detect this difference with
90% power and an alpha of 5%. From previous trials with
similar follow-up methods we anticipate, conservatively,
that 80% of patients randomised will complete a follow-
up questionnaire at 26 weeks [18]. Thus, we need to ran-
domise 185 participants per group. We intend, in
addition, to recruit 185 participants into Group 3 (im-
mediate physiotherapy). Thus, we aimed to randomise
555 participants in total.
Statistical analysis
Analysis will determine whether, at 26 weeks post-
randomisation, patients in Group 1 (advice to remain ac-
tive and maintain usual participation) experience an im-
provement in upper limb pain and function, compared
with those in Group 2 (advice to rest the painful arm). In
addition, we will examine whether, at 26 weeks post-
randomisation, patients who received immediate physio-
therapy (Group 3) experience an improvement in upper
limb pain and function compared with those who received
delayed treatment (from Groups 1 and 2 combined).
Estimation of the treatment effects will be based on
intention-to-treat and will be conducted at the end of the
follow-up period (26 weeks after the final randomisation).
To address the primary research question a logistic regres-
sion model will be fitted to estimate the odds ratio for full
recovery at 26 weeks post-randomisation between Group
1 and Group 2. The model will include treatment group
(as a three-level categorical variable), age (as a continuous
variable, or categorical, depending on the nature of any as-
sociation), and as categorical variables: sex, study centre,
Have you had difficulty with any of the following activities over the PAST 7 DAYS because of an ache
or pain in the elbow, forearm, wrist or hand?
Yes No Not applicable
a. Carrying bags
b. Getting dressed
c. Opening doors
d. Getting things down from high shelves
e. Fastening your clothing
f. Heavy jobs around the house
g. Moving your arm(s) or hand(s)
h. Undoing lids on bottles or jars
i. Writing
j. Driving
k. Sleeping
Figure 1 Modified DASH.
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pain location (elbow, wrist/hand, or both), laterality (dom-
inant, non-dominant, or bilateral) and baseline modified
DASH score (0–5, 6–8, or 9–11). If small numbers in any
of these sub-groups causes problems for model conver-
gence, alternative specifications will be considered.
For the primary analysis of the impact of advice to re-
main active compared to advice to rest, the method of
recycled predictions (using 1000 bootstrap samples) will
be used to estimate the absolute difference in the prob-
ability of being fully recovered between the two groups,
with a 95% confidence interval.
Likewise, for the secondary research question, the im-
pact of early compared to delayed physiotherapy, the
method of recycled predictions (using 1000 bootstrap
samples) will be used to estimate the absolute difference
in the probability of being fully recovered between the
early physiotherapy group and the two delayed physiother-
apy groups combined, with a 95% confidence interval.
Although the main analysis will classify the modified
DASH score dichotomously – i.e. fully recovered (zero
disabilities) or not – as a secondary analysis the modified
DASH score will be considered as a continuous variable.
A linear regression model will be fitted, including the
treatment group, age, sex, study centre, pain location,
laterality and baseline modified DASH score (as a con-
tinuous variable). Again, if small numbers in any of these
sub-groups causes problems for model convergence, al-
ternative specifications will be considered. To assess the
impact of advice to remain active compared with advice
to rest, and to compare early with usual care physiother-
apy, appropriate contrasts will be applied to the coeffi-
cients of the above model to estimate the adjusted mean
differences in modified DASH scores between Groups 1
and 2, and between Group 3 and the mean of Groups 1
and 2 combined, with 95% confidence intervals.
The above analysis will be repeated using the same
outcome measures collected at different assessment time
points (6 and 13 weeks post-randomisation). In addition,
evidence of treatment effect heterogeneity will be
assessed by including terms for interactions between
treatment and each of the other variables in the regres-
sion models.
Finally, a cost-utility analysis will be performed to assess
the health care and patient costs, and quality of life effects,
associated with provision of each of the three treatments.
A series of incremental cost per Quality Adjusted Life
Year (QALY) ratios will be calculated. Sensitivity analysis
will be employed to quantify the uncertainty surrounding
the calculated ratios. In addition, non-parametric methods
will be used for calculating the confidence intervals
around cost per QALY ratios, using bootstrapped esti-
mates of the mean cost and QALY differences. To sum-
marise cost-effectiveness, cost effectiveness acceptability
curves will be employed to show the probability that
different interventions are cost effective for different
values of willingness to pay per additional QALY.
Discussion
We have outlined the rationale and design of a rando-
mised controlled trial to investigate whether, amongst
patients awaiting physiotherapy treatment for distal
upper limb pain, advice to remain active results in a
long-term reduction in arm pain and disability, com-
pared with advice to rest. Further, the trial gives rise to a
pragmatic opportunity to examine whether, among the
same patient population, immediate (‘fast-track’) physio-
therapy results in a long-term reduction in arm pain and
disability, compared with physiotherapy delivered at the
usual time – typically, after a waiting list period of 6–
8 weeks.
Patients awaiting physiotherapy for distal arm pain are
commonly advised to rest the affected limb and avoid
strenuous activities to ‘prevent further injury’. However,
there is currently no sound evidence to support this
strategy. The current trial is novel, in that it tries to ad-
dress this, although similar strategies have been applied
in other areas and have led to enormous clinical benefit.
In low back pain, for >20 yrs the benefits of remaining
active – as opposed to bed-rest, widely advocated at the
time – have been well known. The evidence supporting
maintenance of activity among persons with low back
pain is now well established. Indeed recent studies from
Australia have demonstrated that widespread publicity
campaigns, promoting this message, result in a reduction
in the number of claims for back pain compensation,
and medical payments for back pain in the general
population [19]. However, despite the epidemiological
evidence to suggest that many regional pain syndromes
share common aetiological and prognostic factors [13],
there has been little extrapolation of these principles to
other pain conditions.
The results of this trial will have an immediate influ-
ence on the management of patients with distal arm
pain. Also, depending on the results, it may inform fu-
ture research studies to refine management. For ex-
ample, we may find that there is a worthwhile benefit
from remaining active and maintaining usual activities
while awaiting physiotherapy treatment. If this is the
case, this would provide strong evidence that the advice
currently given to patients with distal arm pain should
be changed. Alternatively, if there is no additional bene-
fit from advice to remain active, this would support the
current treatment strategies and current advice that is
given. It would also provide the stimulus for examining
in more detail the differences between low back pain
and distal arm pain – i.e. why, when the risk factors for
long-term pain and disability are similar, do similar
treatment approaches fail to work?
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In addition, we may find that ‘fast-track’ physiotherapy
has beneficial outcomes, compared to physiotherapy deliv-
ered at the usual time. This would provide good evidence
in support of a rapid-access policy which, in turn, would
translate into clear and immediate patient benefit. It
would be unethical to conduct a study where some pa-
tients received physiotherapy and others did not. However,
if the current trial demonstrates that there is no additional
benefit from early physiotherapy, this would provide the
rationale (and the ethical justification) for randomised tri-
als of specific physiotherapeutic modalities. This might
lead to more refined physiotherapy treatments and more
efficient use of healthcare resources.
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